Opportunity Information: Apply for W81XWH 12 OCRP OCDA
Apply for W81XWH 12 OCRP OCDA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Ovarian Cancer Outcomes Consortium Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Mar 15, 2012 and posted on Mar 15, 2012.
- Applicants must submit their applications by Aug 2, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,280,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Ovarian Cancer Outcomes Consortium Development Award (Funding Opportunity Number W81XWH-12-OCRP-OCDA) is a U.S. Department of Defense Ovarian Cancer Research Program (OCRP) funding opportunity administered through the Department of the Army, USAMRAA. It is designed to build and organize a coordinated, multi-institutional consortium made up of leading ovarian cancer researchers working alongside consumer advocates, with a shared focus on improving understanding of why ovarian cancer patients experience different outcomes. The core purpose is to identify and understand predictors of disease outcomes, meaning factors that may help explain or forecast how patients respond to treatment, how disease progresses, survival differences, recurrence patterns, and other clinically meaningful endpoints.
This award mechanism is specifically described as the first step in a two-stage strategy. The FY12 Outcomes Consortium Development Award funds the early, foundational work needed to make a large collaborative outcomes project feasible and credible. That includes organizing the consortium across institutions, establishing shared priorities and governance, aligning methods, and generating early proof-of-concept results that demonstrate the team can work together and that the proposed approaches are practical. In other words, it supports the groundwork: planning, coordination, and early validation activities that set up a larger research effort.
The second stage is intended to be supported later through a separate mechanism, the FY14 Outcomes Consortium Award, which would fund execution of the full-scale research project. The FY12 Development Award therefore functions as a preparatory investment that reduces risk and strengthens the scientific and operational foundation before committing to a larger, more resource-intensive outcomes consortium effort.
From an administrative and funding standpoint, the opportunity was offered as a discretionary program using grant and/or cooperative agreement funding instruments under the Science and Technology/Research and Development activity category. The program anticipated making two awards, with an estimated total funding amount of $1,280,000. Cost sharing or matching was not required, which typically lowers barriers for applicants and allows participation based more on scientific merit, capability, and consortium readiness rather than an organization s ability to contribute additional funds.
Eligibility was listed as unrestricted, meaning it was broadly open to many types of entities, subject to any additional eligibility clarifications contained in the full announcement. The opportunity was posted and created on March 15, 2012, with an original and final closing date of August 2, 2012, and an archive date of September 1, 2012. The CFDA number associated with this program is 12.420 (Military Medical Research and Development), which indicates it sits within the DoD medical research portfolio.
For applicants or interested parties who had trouble accessing the full announcement, the opportunity provided a CDMRP Help Desk contact (301-682-5507 and help@cdmrp.org), reflecting that the program was managed within the Congressionally Directed Medical Research Programs ecosystem, where multi-institutional, mission-relevant biomedical research initiatives are commonly coordinated and supported.
FAQs: DoD Ovarian Cancer Outcomes Consortium Development Award (W81XWH-12-OCRP-OCDA)
What is the DoD Ovarian Cancer Outcomes Consortium Development Award?
The DoD Ovarian Cancer Outcomes Consortium Development Award (Funding Opportunity Number W81XWH-12-OCRP-OCDA) is a U.S. Department of Defense Ovarian Cancer Research Program (OCRP) funding opportunity administered through the Department of the Army, USAMRAA. It supports the creation and organization of a coordinated, multi-institutional consortium focused on understanding why ovarian cancer patients experience different outcomes.
What is the main goal of this opportunity?
The core goal is to identify and understand predictors of disease outcomes in ovarian cancer. This includes factors that may help explain or forecast treatment response, disease progression, survival differences, recurrence patterns, and other clinically meaningful endpoints.
What does "outcomes" mean in the context of this award?
In this opportunity, "outcomes" refers to clinically meaningful endpoints such as how patients respond to treatment, how disease progresses over time, differences in survival, recurrence patterns, and related measures that help explain variation in patient experiences.
What is meant by "predictors of disease outcomes"?
Predictors of disease outcomes are factors that may help explain or forecast what happens to patients over time, such as differences in treatment response, progression, survival, or recurrence. The award emphasizes understanding these predictors as a way to clarify why outcomes differ among ovarian cancer patients.
Who is expected to be part of the consortium?
The consortium is described as multi-institutional and made up of leading ovarian cancer researchers working alongside consumer advocates, organized around shared priorities to improve understanding of ovarian cancer outcome differences.
Why are consumer advocates included in the consortium?
The opportunity specifically states that the consortium should include consumer advocates working alongside researchers, reflecting an emphasis on including stakeholder perspectives as part of the coordinated effort to focus on meaningful outcomes questions.
Is this award intended to fund full-scale research immediately?
No. This mechanism is described as the first step in a two-stage strategy. The FY12 Outcomes Consortium Development Award funds early, foundational work to make a large collaborative outcomes project feasible and credible.
What types of activities does the FY12 Development Award support?
It supports groundwork activities such as organizing the consortium across institutions, establishing shared priorities and governance, aligning methods, and generating early proof-of-concept results to show the team can work together and that proposed approaches are practical.
What is meant by "proof-of-concept" in this program description?
Based on the description, proof-of-concept refers to early validation results and demonstrations that the consortium can coordinate effectively and that the approaches being proposed can work in practice, helping reduce risk before a larger effort is funded.
How does this award relate to later funding?
This award is intended to prepare for a later, separate mechanism: the FY14 Outcomes Consortium Award, which is described as the funding source for executing the full-scale research project. The FY12 Development Award is positioned as a preparatory investment to strengthen the scientific and operational foundation.
What is the anticipated number of awards and total funding?
The program anticipated making two awards, with an estimated total funding amount of $1,280,000.
Is cost sharing or matching required?
No. Cost sharing or matching was not required for this opportunity.
What type of funding instrument is used?
The opportunity was offered as a discretionary program using grant and/or cooperative agreement funding instruments.
What is the activity category for this funding opportunity?
The activity category is listed as Science and Technology/Research and Development.
Who administers this opportunity?
It is administered through the Department of the Army, USAMRAA, under the DoD Ovarian Cancer Research Program (OCRP) within the Congressionally Directed Medical Research Programs ecosystem.
What is the CFDA number for this program?
The CFDA number associated with this program is 12.420 (Military Medical Research and Development), placing it within the DoD medical research portfolio.
Who is eligible to apply?
Eligibility was listed as unrestricted, meaning it was broadly open to many types of entities, subject to any additional eligibility clarifications contained in the full announcement.
When was the opportunity posted and when did it close?
The opportunity was posted and created on March 15, 2012. The original and final closing date was August 2, 2012.
Has this opportunity been archived?
Yes. The archive date provided is September 1, 2012.
What should applicants do if they cannot access the full announcement?
The opportunity lists the CDMRP Help Desk as the point of contact for access issues: 301-682-5507 and help@cdmrp.org.
What is the purpose of funding a development award instead of directly funding a large consortium project?
The description explains that the development award reduces risk and strengthens the scientific and operational foundation by supporting planning, coordination, method alignment, governance, and early validation activities before committing to a larger, more resource-intensive outcomes consortium effort.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: NLM Information Resource Grants to Reduce Health Disparities (G08)
Previous opportunity: In vivo Nanoplatforms for Diagnostics (IVNDx)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 12 OCRP OCDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 12 OCRP OCDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| Habitat and Population Evaluation Apply for F12AS00103 Funding Number: F12AS00103 Agency: Fish and Wildlife Service Category: Science and Technology and other Research and Development Funding Amount: $32,650 |
| NIST Consortium for Post Complementary Metal Oxide Semiconductor (CMOS) Nanoelectronics Research Grant Program Apply for 2012 NIST POST CMOS 01 Funding Number: 2012 NIST POST CMOS 01 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY11 Militarily Relevant Peer Reviewed Alzheimers Disease Research Program (MRPRA) Translational Research Award Apply for W81XWH 11 MRPRA TRA Funding Number: W81XWH 11 MRPRA TRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| DoD Prostate Cancer Biomarker Development Award Apply for W81XWH 12 PCRP BDA Funding Number: W81XWH 12 PCRP BDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2012 Planetary Astronomy Apply for NNH12ZDA001N PAST Funding Number: NNH12ZDA001N PAST Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ROSES 2012 Heliophysics Research Geospace Science Apply for NNH12ZDA001N GEO Funding Number: NNH12ZDA001N GEO Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Clinical Exploration Award Apply for W81XWH 12 PCRP CEA Funding Number: W81XWH 12 PCRP CEA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Laboratory Clinical Transition Award Apply for W81XWH 12 PCRP LCTA Funding Number: W81XWH 12 PCRP LCTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Transformative Impact Award Apply for W81XWH 12 PCRP TIA Funding Number: W81XWH 12 PCRP TIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Idea Development Award Apply for W81XWH 12 PCRP IDA Funding Number: W81XWH 12 PCRP IDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Synergistic Idea Development Award Apply for W81XWH 12 PCRP SIDA Funding Number: W81XWH 12 PCRP SIDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Scientific Collaborations at Extreme Scale Apply for DE FOA 0000695 Funding Number: DE FOA 0000695 Agency: Office of Science Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 |
| Small Business Innovation Research Program Phase I Solicitation FY 2013 Apply for 12 548 Funding Number: 12 548 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Frontiers in Earth System Dynamics Apply for 12 547 Funding Number: 12 547 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Biologically derived Medicines on Demand (Bio MOD) Apply for DARPA BAA 12 37 Funding Number: DARPA BAA 12 37 Agency: DARPA Defense Sciences Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Collaborative Undergraduate HBCU Student Summer Training Program Award Apply for W81XWH 12 PCRP STPA Funding Number: W81XWH 12 PCRP STPA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Physician Research Training Award Apply for W81XWH 12 PCRP PRTA Funding Number: W81XWH 12 PCRP PRTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Postdoctoral Training Award Apply for W81XWH 12 PCRP PTA Funding Number: W81XWH 12 PCRP PTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Health Disparity Research Award Apply for W81XWH 12 PCRP HDRA Funding Number: W81XWH 12 PCRP HDRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Exploration Hypothesis Development Award Apply for W81XWH 12 PCRP EHDA Funding Number: W81XWH 12 PCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 12 OCRP OCDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.